GlaxoSmithKline (GSK) plc has announced a new four year contract with the Biomedical Advanced Research and Development Authority (BARDA), part...
Read moreNovartis has invited 60 selected students from leading international universities in 21 countries to its headquarters in Switzerland for the...
Read moreThe European Medicines Agency (EMA) and the United States Food and Drug Administration (US FDA) have published a joint question-and-answer...
Read moreNovartis is the first company to earn global CEO Cancer Gold Standard accreditation by the non-profit organization CEO Roundtable on...
Read moreNovartis has announced that results of a global Phase III study showed that Afinitor® (everolimus) did not extend overall survival...
Read moreGlaxoSmithKline (GSK) has increased its commitment to the GAVI Alliance to provide vaccines to developing countries, helping to protect millions...
Read morePublished in the European Journal of Heart Failure1, results from a new sub-analysis of the RE-LY®* trial demonstrate important benefits...
Read moreNew data on an emerging treatment that aims to fight colorectal cancer by stimulating the immune system have been presented...
Read moreA promising new treatment for breast cancer being developed at Virginia Commonwealth University Massey Cancer Center and the VCU Institute...
Read moreAstraZeneca announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc. have entered into an exclusive...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
